# Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes

> **NCT01384058** · PHASE4 · COMPLETED · sponsor: **University Hospital Freiburg** · enrollment: 41 (actual)

## Conditions studied

- Diabetes Mellitus Type 2
- Hypercholesterolemia

## Interventions

- **DRUG:** ezetimibe
- **DRUG:** simvastatin
- **DRUG:** Ezetimibe 10/Simvastatin 20

## Key facts

- **NCT ID:** NCT01384058
- **Lead sponsor:** University Hospital Freiburg
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-05
- **Final completion:** 2010-06
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2012-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01384058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01384058, "Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01384058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*